Controlled documentation
SOPs, technical-documentation records, and change approvals managed in one governed path — not scattered across document stores and trackers that fail under review.
Last reviewed: Jun 12, 2026 · Next review: Sep 12, 2026
MDR compliance software should keep design, document control, complaint and vigilance handling, CAPA, risk, and change records connected — so technical documentation holds together under notified-body scrutiny instead of fragmenting across tools.
The EU Medical Device Regulation (EU 2017/745, MDR) raised the evidence bar for device manufacturers across technical documentation, clinical evaluation, post-market surveillance, and vigilance. With the 2023/607 transition extensions now running to 31 December 2027 and 31 December 2028 by device class, the quality-system foundation has to be defensible well before those dates. This page helps device buyers assess software fit through an MDR lens, then connect that review to the broader ISO 13485 buyer guide and the medical device industry page.
MDR buying decisions are still quality-system decisions — but the emphasis shifts to technical-documentation traceability, vigilance, and lifecycle change control.
Device teams need more than generic QMS coverage. They need software that keeps design, complaint, vigilance, risk, and post-market evidence connected and reconstructable.
MDR evaluation centers on technical-documentation traceability (Annexes II/III), complaint-to-vigilance-to-CAPA linkage, controlled change, post-market surveillance evidence, and how quality records hold up to notified-body review.
Buyers often assume ISO 13485 coverage equals MDR readiness. It is the baseline, not the whole picture — the MDR adds clinical evaluation, PMS/PMCF, vigilance, UDI, and EUDAMED obligations a QMS platform supports but does not replace.
MDR software should make traceability easier to defend, not harder to reconstruct.
SOPs, technical-documentation records, and change approvals managed in one governed path — not scattered across document stores and trackers that fail under review.
MDR fit improves when complaints connect directly to investigation, vigilance assessment, risk review, and CAPA without handoffs across separate systems.
A change should be traceable through approval, document revision, risk re-assessment, training, and verification — visible, not buried in email and spreadsheets.
PMS and trending data should connect back to CAPA and risk so the post-market loop is a record trail, not a periodic scramble.
Many device teams also need ISO 13485, FDA QMSR, and Part 11 fit. Cross-reference the adjacent buyer guides before committing to one platform.
Even when the conversation starts with quality-process fit, the digital workflow itself needs qualification evidence and inspectable controls.
Be precise about the line between quality-system records and regulatory submissions.
Controlled technical-documentation records, complaint handling into investigation and CAPA, design and change traceability, ISO 14971 risk management, and training evidence — the records the MDR's Article 10 QMS expectation rests on.
Vigilance reporting to authorities, UDI assignment, and EUDAMED registration are regulatory-submission functions. A QMS platform feeds the evidence; it does not file on your behalf.
Don't separate software fit from validation. The same procurement decision should answer how the digital workflow itself is qualified and how the validated state is maintained.
These keep the shortlist grounded in device-workflow reality.
Ask for a workflow demonstration showing a complaint moving into investigation, vigilance assessment, CAPA, document updates, and training without losing traceability.
A clear answer separates the quality-system records (which a QMS platform governs) from vigilance filing, UDI, and EUDAMED registration (which it does not). Beware of platforms that blur the two.
The answer should include qualification evidence, change control, and how the validated state is maintained over the lifecycle of the software.
A software-selection guide for IVD teams comparing IVDR readiness, ISO 13485 fit, traceability, and complaint workflow support.
Read →6 platforms scored against ISO 13485:2016 — Document Control, Design Controls, Risk Management (ISO 14971), CAPA, Internal Audits, validation pack.
Read →6 platforms scored against FDA QMSR (effective 2026-02-02): ISO 13485 alignment, DHF, UDI, complaint handling, validation pack per module.
Read →Seven vendors evaluated side-by-side for regulated life sciences: Veeva, MasterControl, Qualio, Greenlight Guru, ETQ/Octave, TrackWise Digital, Complere.
Read →Hub of vendor comparisons with how-to-evaluate guide and per-vendor 14-criteria scoring matrices.
View hub →Review Complere against MDR complaint and vigilance handling, technical-documentation traceability, risk, change, and validation in one conversation — with the boundary to submission tooling stated plainly.